A resident of Grays Harbor County, Washington state, United States has died after becoming the first person known to be infected with an H5N5 avian influenza virus, US public‑health officials confirmed in mid‑November.

The fatal case coincides with an unusually early and active seasonal influenza period in many countries, driven largely by A/H3N2 subclade K, raising fresh concerns for hospitals in northern hemisphere already preparing for a difficult winter.

The patient, an older adult with underlying health conditions who kept backyard poultry, became severely unwell in early November with high fever, respiratory distress and confusion.

Tests on 14 November identified infection with an H5N5 influenza A virus; the person was treated in hospital but died on 21 November. Local authorities say the household poultry had been exposed to wild birds, making zoonotic transmission the most likely source, according to The Conversation.

What is H5N5 and How Serious is it?

H5N5 is an avian influenza A virus. Like the more widely reported H5N1, it carries an H5 haemagglutinin protein on its surface, but it has a different neuraminidase protein (N5). H5N5 circulates in wild birds and often spills into poultry flocks; this is the first documented instance of the virus infecting a human.

While the case highlights that H5N5 can cause severe disease in humans, scientists stress that most avian influenza “spillovers” are isolated and do not lead to sustained human‑to‑human transmission. There is currently no evidence that this H5N5 infection spread to other people.

Nonetheless, avian influenza viruses are monitored closely because, although adaptation to sustained human transmission is rare, it is the mechanism by which past influenza pandemics have arisen.

Seasonal Flu: Earlier Start and an H3N2 Surge

Separately, the northern‑hemisphere influenza season has started earlier than usual in several countries. Japan and parts of Europe — including Spain and the United Kingdom — are reporting above‑expected case numbers, and the United States and Canada show similar trends.

The season is being driven mainly by A/H3N2 viruses, specifically the subclade known as K (also referred to as J.2.4.1). Subclade K has been detected on all continents and accounted for a substantial share of A/H3N2 viruses analysed between May and November 2025.

Public‑health experts say this subclade represents normal mutation of an H3N2 strain that has circulated among humans since 1968.

Current evidence does not indicate greater virulence, increased resistance to antiviral drugs, or markedly higher severity in affected countries.

However, H3N2‑dominated seasons typically lead to more hospital admissions and worse outcomes in older adults, and vaccines often perform less well against H3N2 than against other subtypes.

Vaccine Implications and Recommendations

This season’s vaccine was formulated from data collected before subclade K became widespread. Some laboratory analyses indicate antigenic differences between subclade K and the H3N2 vaccine component; real‑world effectiveness data are still limited.

Despite potential mismatch, vaccination remains the best defence against severe illness and is recommended for everyone eligible.

Public‑Health Priorities and Practical Advice

Officials from various agencies urge continued vigilance on both fronts:

• For avian influenza: enhanced surveillance, rapid testing and sequencing, prompt investigation of severe respiratory cases with animal exposure, and strengthened biosecurity and monitoring in poultry. Where policy allows, vaccination of poultry and measures such as indoor housing and culling of infected flocks are used to limit spread among birds and reduce zoonotic risk.
• For seasonal influenza: early vaccination, good hand hygiene, mask use when symptomatic or in crowded indoor spaces, staying home if unwell, and prioritising protection of older adults and people with chronic conditions.

Clinicians and health systems globally are advised to maintain surge preparedness — ensuring antiviral supplies, clear triage protocols and capacity planning — as many countries may face increased winter pressure.

Our Conclusion

Public‑health specialists describe the H5N5 human case as a rare and tragic zoonotic event rather than evidence of human spread. However, the coincident early surge in seasonal influenza, led by A/H3N2 subclade K, suggests a busier and potentially more severe season ahead. Authorities will continue genomic surveillance of both avian and human influenza viruses and urge the public to get vaccinated without delay and follow standard infection‑control measures.